Cefixime USP
Composition : Cefixime USP 25mg/ml Paediatric Drops, 100mg/5ml & 200mg/5ml Suspension.
Indication : Cefixime is generally classified as a third-generation cephalosporin antibiotic and is given by mouth in the treatment of susceptible infections, including gonorrhoea, otitis media, pharyngitis, lower respiratory-tract infections such as bronchitis and urinary tract infections and Shigellosis, caused by Shigella flexneri (54%), S. boydii (30%), S. dysenteriae non-type 1 (6%) and S. Sonnei (10%).
Dosage and administration : Adults : The recommended dose of T-cef is 400mg daily. This may be given as 200mg capsule every 12 hours. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of 400mg is recommended.Typhoid fever : Oral T-cef 5mg/kg 12 hourly for 14 days. Shigellosis : 8mg/kg/day as a single dose or in 2 divided doses for 5 days.
Paediatric (6 Months or older) : The
recommended dose is 8mg/kg/day of the suspension. This may be administered as a
single daily dose or may be given in two divided doses, as 4mg/kg every 12
hours.
Typhoid fever : Oral T-cef 5mg/kg 12 hourly for
14 days.
Shigellosis : 8mg/kg/day as a single dose or in
2 divided doses for 5 days. Or, as directed by the registered physician.
Please see prescribing description for more information.
Use in pregnancy and lactation : : Cefixime has been assigned to pregnancy category B. by the FDA.
Packing : T-cef Paediatric Drops : 21ml suspension.
T-cef Suspension : 30ml, 50ml suspension.
T-cef DS : 50ml suspension.
